netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US

Divestment of non-core assets to align portfolio

Aug 7, 2015
-
News, RNS Announcements
RNS Number : 3824V
NetScientific PLC
07 August 2015

 

NetScientific plc

 

NetScientific divests non-core assets to align its healthcare portfolio 

 

London, UK – 7 August 2015 – NetScientific plc (“NetScientific” or the “Group”, AIM: NSCI), the transatlantic biomedical and healthcare technology group, announces that as part of an ongoing review of its portfolio, it has started to divest certain projects that fall outside of its core areas of focus.

 

As a result of this process, NetScientific has now divested control of RoboScientific Ltd to management. The Group has also started to divest its other non-healthcare company, MOF Technologies Ltd, and is discontinuing support for certain projects and companies, including Morphodyne SA, Qlida Diagnostics, Inc. and Advanced Biosensors, Inc. A full update will be included in the interim results. 

 

These strategic decisions have been made as the Group continues to re-align the portfolio to focus on its three core areas in healthcare. These are sectors with attractive growth markets where breakthrough technology solutions are in high demand. The Group will be concentrating on its lead companies and further strengthening its relationships with strategic partners to build a unique transformative portfolio. 

 

Francois Martelet, CEO of NetScientific, said: “Our focus is firmly set on accelerating growth of our lead companies whilst continuing to work with the best and most innovative institutions with breakthrough technologies in our core areas of focus – digital health, diagnostics and therapeutics.”

 

-Ends-

 

Notes to Editors

 

About NetScientific

NetScientific is a biomedical and healthcare technology group that funds and develops technologies that offer transformative benefits to people’s lives and society through improved diagnosis, prognosis and treatment. For more information, please visit the website at www.netscientific.net. 

 

About RoboScientific Ltd

RoboScientific is developing a range of highly sensitive electronic sensors that are able to act as an ‘electronic nose’ enabling the detection of extremely small traces of volatile chemical compounds. For more information, please visit the website at www.roboscientific.com

 

About MOF Technologies Ltd

MOF Technologies has developed a novel technique for the synthesis of MOFs, which is environmentally friendly, rapid and highly scalable, allowing cost-effective, large-scale deployment of these revolutionary materials. MOFs are highly porous materials that can store, separate and capture specific gases. They have a range of high-value applications, including natural gas storage in vehicles, carbon capture, catalysis and drug delivery. For more information, please visit the website at www.moftechnologies.com

 

 

Contact Details

NetScientific

François Martelet, CEO

Peter Thoms, CFO

Tel: +44 (0)20 3514 1800

Investec

Gary Clarence / Daniel Adams

Tel: +44 (0)20 7597 4000

Instinctif Partners

Melanie Toyne-Sewell / Jayne Crook

Tel: +44 (0)20 7457 2020 Email: netscientific@instinctif.com

This information is provided by RNS
The company news service from the London Stock Exchange

END

DISFQLLBEVFFBBD

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
Steve Curd appointed as CEO of Wanda
NEXT POST →
ProAxsis launches first-in-class ProteaseTag™ test

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
Copyright
Terms of Use
Divestment of non-core assets to align portfolio - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT